THIS PROFILE IS FROM 2006, AND CONTAINS INFORMATION THAT MAY NO LONGER BE CURRENT.
#7 MedImmune
1 Medimmune Way
Gaithersburg, MD 20878
Tel: (877) 633-4411
Fax: (301) 398-9000
www.medimmune.com
| Headcount |
2,215 |
|
| Year Established |
1988 |
|
| Biopharma Revenues |
$1,221 |
+9% |
| Total Revenues |
$1,244 |
+9% |
| Royalty Revenues |
$23 |
+35% |
| Net Loss |
-$17 |
n/a |
| R&D Budget |
$385 |
+18% |
Drugs Pending Approval
|
| Drug |
Indication |
| medi-545 |
lupus |
| caiv-t |
refrigerator-stable formulation of FluMist |
| Drugs in Phase IIb and Beyond |
| Drug |
Indication |
| numax Mab |
lower respiratory tract disease from RSV |
| epstein-barr vaccine |
Epstein-Barr virus |
| abegrin |
prostate cancer, melanoma |
| HPV vaccine |
cervical cancer from HPV |
| ethyol |
mucositis |
Early Research Projects
|
| Drug |
Indication |
| rsv vaccine |
respiratory syncytial virus |
| vaccine programs |
hMPV and PIV-3 |
| mt-103 |
B-cell lymphoma and leukemia |
| ephA2 |
oncology |
| ephA4 |
pancreatic cancer |
| hMGB-1 |
rheumatoid arthritis |
| siplizumab |
T-cell lymphoma |
| Top Selling Drugs |
| Drug |
Indication |
Sales |
(+/-%) |
| synagis |
respiratory syncytial virus |
$1,063 |
+13% |
| ethyol |
renal toxicity from chemotherapy |
$95 |
+3% |
| flumist |
influenza |
$21 |
-56% |
Account for 97% of total biopharma sales, up from 96% in 2004.
Magazine
